Pharmaceutical composition containing botulinum neurotoxin A2
A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of : (a) a much longer duration of action; (b) a much faster rate of onset of muscular paralysis; (c) a signific...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; hun |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Webb, Paul Panjwani, Naveed Pickett, Andrew |
| description | A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of :
(a) a much longer duration of action;
(b) a much faster rate of onset of muscular paralysis;
(c) a significantly greater intramuscular safety margin;
(d) a selective action on inhibition of skeletal muscle contraction;
(e) a selective action on inhibition of pain-related (nociceptive) nerve cell function, wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE032950TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE032950TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE032950TT23</originalsourceid><addsrcrecordid>eNrjZLANyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzwOy80oSM_My89IVkvJLSnMy80pzFfJSS4vyS_IrMvMUHI14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcQHQ3LzUkniPUFcDYyNLU4OQECNjYtQAAJelMYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition containing botulinum neurotoxin A2</title><source>esp@cenet</source><creator>Webb, Paul ; Panjwani, Naveed ; Pickett, Andrew</creator><creatorcontrib>Webb, Paul ; Panjwani, Naveed ; Pickett, Andrew</creatorcontrib><description>A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of :
(a) a much longer duration of action;
(b) a much faster rate of onset of muscular paralysis;
(c) a significantly greater intramuscular safety margin;
(d) a selective action on inhibition of skeletal muscle contraction;
(e) a selective action on inhibition of pain-related (nociceptive) nerve cell function, wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1.</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171128&DB=EPODOC&CC=HU&NR=E032950T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171128&DB=EPODOC&CC=HU&NR=E032950T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Webb, Paul</creatorcontrib><creatorcontrib>Panjwani, Naveed</creatorcontrib><creatorcontrib>Pickett, Andrew</creatorcontrib><title>Pharmaceutical composition containing botulinum neurotoxin A2</title><description>A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of :
(a) a much longer duration of action;
(b) a much faster rate of onset of muscular paralysis;
(c) a significantly greater intramuscular safety margin;
(d) a selective action on inhibition of skeletal muscle contraction;
(e) a selective action on inhibition of pain-related (nociceptive) nerve cell function, wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLANyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzwOy80oSM_My89IVkvJLSnMy80pzFfJSS4vyS_IrMvMUHI14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcQHQ3LzUkniPUFcDYyNLU4OQECNjYtQAAJelMYw</recordid><startdate>20171128</startdate><enddate>20171128</enddate><creator>Webb, Paul</creator><creator>Panjwani, Naveed</creator><creator>Pickett, Andrew</creator><scope>EVB</scope></search><sort><creationdate>20171128</creationdate><title>Pharmaceutical composition containing botulinum neurotoxin A2</title><author>Webb, Paul ; Panjwani, Naveed ; Pickett, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE032950TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Webb, Paul</creatorcontrib><creatorcontrib>Panjwani, Naveed</creatorcontrib><creatorcontrib>Pickett, Andrew</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Webb, Paul</au><au>Panjwani, Naveed</au><au>Pickett, Andrew</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition containing botulinum neurotoxin A2</title><date>2017-11-28</date><risdate>2017</risdate><abstract>A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of :
(a) a much longer duration of action;
(b) a much faster rate of onset of muscular paralysis;
(c) a significantly greater intramuscular safety margin;
(d) a selective action on inhibition of skeletal muscle contraction;
(e) a selective action on inhibition of pain-related (nociceptive) nerve cell function, wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; hun |
| recordid | cdi_epo_espacenet_HUE032950TT2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS |
| title | Pharmaceutical composition containing botulinum neurotoxin A2 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T22%3A50%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Webb,%20Paul&rft.date=2017-11-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE032950TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |